Patients' use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: A cross-sectional survey in medical in-patients

Drug Safety

Volumn 36, Issue 8, 2013, Pages 673-680

  Krska, Janet ^a,b   Morecroft, Charles W ^a  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVERSE DRUG REACTION; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DRUG SURVEILLANCE PROGRAM; EDUCATIONAL STATUS; FEMALE; HEALTH PRACTITIONER; HEALTH SURVEY; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH SERVICE; NURSE; PATIENT INFORMATION; PATIENT INFORMATION LEAFLET; PERSONAL EXPERIENCE; PHARMACIST; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; INPATIENTS; MALE; MIDDLE AGED;

EID: 84881139846     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.1007/s40264-013-0065-3     Document Type: Article

References (20)

1. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients. BMJ. 2004;329:15-9.
2. Davies EC, Green CF, Taylor S, et al. Adverse drug reactions in hospital in-patients: a prospective analysis of 3965 patient-episodes. PLoS One. 2009;4(2):e4439. doi: 10.1371/journal.pone.0004439.
3. Ghandi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. New Engl J Med. 2003;348(16):1556-64.
4. Weingart SN, Gandhi TK, Seger AC, Seger DL, Borus J, et al. Patient-reported medication symptoms in primary care. Arch Intern Med. 2005;165:234-40.
5. Jarernsiripornkul N, Krska J, Capps PAG, Richards RME, Lee A. Patient reporting of potential adverse drug reactions: a methodological study. Br J Clin Pharmacol. 2002;53:318-25.
6. Carpay JA, Aldenkamp AP, van Donselaar CA. Complaints associated with anti-epileptic drugs: results from a community-based study. Seizure. 2005;14:198-206.
7. Krska J, Jones L, McKinney J, Wilson C. Medicines safety: experiences and perceptions of the general public in Liverpool. Pharmacoepidemiol Drug Saf. 2011;20(10):1098-103.
8. Avery AJ, et al. Evaluation of patient reporting of ADRs through the Yellow Card Scheme: final report. Health Technol Assess 2011;15:20. Available from URL: http://www.hta.ac.uk/project/1628.asp. Accessed 26 Apr 2013.
9. Krska J, Anderson CA, Murphy E, Avery AJ, on behalf of the Yellow Card Study Collaboration. How patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK Yellow Card Scheme. Drug Saf. 2011;34(5):429-36.
10. van Grootheest AC, de Jong-van den Berg L. Review: patients' role in reporting adverse drug reactions. Exp Opin. Drug Saf. 2004;3:363-8.
11. Golomb BA, McGraw JJ, Evans MA, et al. Physician response to patient reports of adverse drug effects. Drug Saf. 2007;30:669-75.
12. Anderson CA, Krska J, Murphy E, Avery AJ, on behalf of the Yellow Card Study Collaboration. The importance of direct patient reporting of ADRs: a patient perspective. Br J Clin Pharmacol. 2011;72(5):806-22.
13. Krska J, Morecroft CW. Informing patients about medicines: a hospital in-patient survey in England. Patient Educ Couns. 2013;90:276-8.
14. Raynor DK, Silcock J, Knapp P, Edmondson H. How do patients use medicine information leaflets in the UK? Int J Pharm Pract. 2007;15:209-18.
15. Raynor DK, Blenkinsopp A, Knapp P, Grime J, Nicolson DJ, Pollock K, et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess. 2007;11(5):1-98.
16. Lamb GC, Green SS, Heron J. Can physicians inform patients about potential side effects without fear of causing those side effects? Arch Intern Med. 1994;154:2753-6.
17. Howland JS, Baker MG, Poe T. Does patient education cause side effects? A controlled trial. J Fam Pract. 1990;31:62-4.
18. Myers ED, Calvert EJ. The effect of forewarning on the occurrence of side effects and discontinuance of medication in patients on dothiepin. J Int Med Res. 1976;4:237-40.
19. Nunes V, Neilson J, O'Flynn N, Calvert N, Kuntze S, Smithson H, et al. Clinical guidelines and evidence review for medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners; 2009.
20. Ziegler DK, Mosier MC, Bauenaver M, Okuyemi K. How much information about adverse effects of medication do patients want from physicians? Arch Intern Med. 2001;161(5):706-13.